Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
13.79
-0.22 (-1.57%)
At close: Sep 8, 2025, 4:00 PM
13.81
+0.02 (0.15%)
After-hours: Sep 8, 2025, 4:00 PM EDT
Outset Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Outset Medical stock has a target of 22, which predicts a 59.54% increase from the current stock price of 13.79.
Price Target: $22 (+59.54%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Outset Medical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $22 | Hold | Reiterates | $22 | +59.54% | Aug 19, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +59.54% | Aug 7, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $14 → $21 | Hold | Maintains | $14 → $21 | +52.28% | May 21, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $12 → $14 | Hold | Maintains | $12 → $14 | +1.52% | May 8, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $45 | Hold | Reiterates | $45 | +226.32% | Jan 7, 2025 |
Financial Forecast
Revenue This Year
127.75M
from 113.69M
Increased by 12.37%
Revenue Next Year
141.19M
from 127.75M
Increased by 10.52%
EPS This Year
-4.43
from -36.95
EPS Next Year
-2.68
from -4.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 130.7M | 147.0M | |||
| Avg | 127.8M | 141.2M | |||
| Low | 121.3M | 131.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 15.1% | |||
| Avg | 12.4% | 10.5% | |||
| Low | 6.7% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.10 | -2.26 | |||
| Avg | -4.43 | -2.68 | |||
| Low | -5.18 | -3.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.